Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).

1 Oct 2012

September issue of JNCCN publishes two prostate cancer articles

Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN - The Journal of the National Comprehensive Cancer Network. The articles review and clarify recent updates made to the National Comprehensive Cancer Network's (NCCN) guidelines for the screening and treatment of prostate cancer.

29 Sep 2012

Mount Sinai surgeon offers tips to prevent prostate cancer

World-renowned Mount Sinai robotic prostate surgeon, Dr. David Samadi, devotes much of his time to prostate cancer education domestically and internationally. "My SMART robotic prostate removal surgery saves lives, but what men really want to know is how to prevent prostate cancer in the first place," shares Dr. Samadi.

29 Sep 2012

ACS honors world-leader in robotic prostate surgery with 2012 Community Partner Award

At last night's Annual Prostate Cancer Awareness and Education Dinner, the American Cancer Society awarded Dr. David B. Samadi, world-leader in prostate cancer treatment and robotic prostate surgery, with the 2012 Community Partner Award. Through robotic surgery excellence, Dr. Samadi has successfully cured more than 4,000 men of prostate cancer.

29 Sep 2012

First Edition: September 28, 2012

Today's headlines include reports about political and policy-oriented health care developments.

28 Sep 2012

Contrast-enhanced ultrasound effective in diagnosing men with high-grade prostate cancer

Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk ones with less biopsies, researchers from Thomas Jefferson University and Hospitals conclude in a phase III study published online in September in the Journal of Urology.

28 Sep 2012

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

Janssen-Cilag International NV announced today that the European Commission has approved the marketing authorisation for DACOGEN(decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.

28 Sep 2012

OncoGenex commences custirsen Phase 3 trial in non-small cell lung cancer

OncoGenex Pharmaceuticals, Inc. announced today the initiation of ENSPIRIT, a Phase 3 trial evaluating custirsen for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have progressed after initial chemotherapy treatment has failed.

28 Sep 2012

Scientists discover 12 genetic markers for ED in prostate cancer patients after radiotherapy

In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction (ED) in prostate cancer patients who were treated with radiation.

27 Sep 2012

Henry Ford Hospital opens new Center for Cancer Surgery

With more patients seeking cancer treatment – especially surgery – than ever before, Henry Ford Hospital has opened the new Center for Cancer Surgery.

27 Sep 2012

Increasing doses of radium chloride effective, tolerated in prostate cancer

Radium chloride treatment has dose-dependent beneficial effects on health outcomes in patients with castration-resistant prostate cancer and bone metastases, report researchers.

26 Sep 2012

The ABC of terminal hemorrhage management

To best cope with terminal hemorrhage, at-risk patients should be identified by healthcare professionals while their families and caregivers are prepared, supported, and instructed to assure, be there for, and calm and comfort the patient as the event occurs, say researchers.

26 Sep 2012

Armband labeling could prevent DNR confusion

Implementation of an electronic ordering and armband labeling process for patients with Do Not Resuscitate orders improved correct documentation of their wishes as well as physicians’ ability to recognize and act on them during a cardiac arrest scenario, report US researchers.

25 Sep 2012

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers at Mayo Clinic's campus in Florida. Their recent study, published in the online edition of Psycho-Oncology, suggests that men who experience high levels of "cancer-specific anxiety" following surgery for prostate cancer could likely benefit from counseling designed to address their worries and improve their quality of life.

25 Sep 2012

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment, "active surveillance" has emerged as a plausible option, encouraged for men whose tumors may not need immediate treatment and may never progress to more serious illness. Appropriate criteria for selecting patients for active surveillance are continuously debated.

25 Sep 2012

Anti-androgen therapies may benefit bladder cancer patients

Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24. A University of Colorado Cancer Center study published today in the Proceedings of the National Academy of Sciences shows that CD24 expression may depend on androgens - and that anti-androgen therapies like those currently used to treat prostate cancer may benefit bladder cancer patients.

25 Sep 2012

Protect Your Manhood, ZERO collaborate to address prostate health

ZERO – The End of Prostate Cancer is partnering with Protect Your Manhood, a New Hampshire seacoast based start-up founded by prostatitis survivor and marketing maven Chris Sargent, which offers a culturally relevant resource to promote prostate health.

25 Sep 2012

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

ASTRO's Annual Meeting is the premier scientific meeting in radiation oncology and is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world.

24 Sep 2012

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

On Aug. 8, Massachusetts' third health care cost control bill became law. It "sets annual state spending targets, encourages the formation of accountable care organizations, and establishes an independent commission to oversee health care system performance."

21 Sep 2012

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Lilly announces new data from two Phase II ramucirumab trials on NSCLC

September issue of JNCCN publishes two prostate cancer articles

Mount Sinai surgeon offers tips to prevent prostate cancer

ACS honors world-leader in robotic prostate surgery with 2012 Community Partner Award

First Edition: September 28, 2012

Contrast-enhanced ultrasound effective in diagnosing men with high-grade prostate cancer

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

OncoGenex commences custirsen Phase 3 trial in non-small cell lung cancer

Scientists discover 12 genetic markers for ED in prostate cancer patients after radiotherapy

Henry Ford Hospital opens new Center for Cancer Surgery

Increasing doses of radium chloride effective, tolerated in prostate cancer

The ABC of terminal hemorrhage management

Armband labeling could prevent DNR confusion

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Endorectal MRI helps assess eligibility of men with prostate cancer for active surveillance

Anti-androgen therapies may benefit bladder cancer patients

Protect Your Manhood, ZERO collaborate to address prostate health

ASTRO's Annual Meeting to be held in Boston from Oct. 28-31

Research roundup: 'Early' cost-control lessons from Mass.; Colonoscopy coverage; Impact of PSA recommendations

MD Anderson introduces Moon Shots Program to reduce cancer deaths

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in